Insider buying
~$36K3,600 sh @ $9.88
Traded Apr 25, 2025 · filed 4 days later
The CEO of Greenwich Lifesciences paid $36K out of pocket for Greenwich Lifesciences shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 7, 2025 · Filed Apr 8, 2025
The CEO of Greenwich Lifesciences paid $33K out of pocket for Greenwich Lifesciences shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$32,760
Shares × reported transaction price
$25K–$100K
+0.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 8 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.3% | −4.2% | −2.1% |
| 30 days | 0.0% | +2.9% | −2.9% |
| 90 days | +7.0% | +13.1% | −6.1% |
| 180 days | +19.6% | +22.4% | −2.8% |
| 365 days | +173.8% | +23.9% | +149.9% |
Past results only. Not a forecast.
Insider buying
Traded Apr 25, 2025 · filed 4 days later
The CEO of Greenwich Lifesciences paid $36K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Apr 17, 2025 · filed 5 days later
The CEO of Greenwich Lifesciences paid $48K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Apr 4, 2025 · filed 3 days later
The CEO of Greenwich Lifesciences paid $48K out of pocket for Greenwich Lifesciences shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Snehal Patel, CEO and CFO's past purchases, 90 days after disclosure: 21 buys, median −4.3 pts vs S&P 500, beat it 10 of 21 times. Past results, not a forecast.